HIV vaccine design: insights from live attenuated SIV vaccines-Reference-Cited by-同舟云学术

HIV vaccine design: insights from live attenuated SIV vaccines

Published:2005-12-15 Issue:1 Volume:7 Page:19-23
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Koff Wayne C,Johnson Philip R,Watkins David I,Burton Dennis R,Lifson Jeffrey D,Hasenkrug Kim J,McDermott Adrian B,Schultz Alan,Zamb Timothy J,Boyle Rosanne,Desrosiers Ronald C

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni1296.pdf

Reference46 articles.

1. Desrosiers, R.C. Prospects for an AIDS vaccine. Nat. Med. 10, 221–223 (2004).

2. Horton, H. et al. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J. Virol. 76, 7187–7202 (2002).

3. Casimiro, D.R. et al. Attenuation of simian immunodeficiency virus SIVmac239 Infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79, 15547–15555 (2005).

4. Ourmanov, I. et al. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV. J. Virol. 74, 2740–2751 (2000).

5. Hanke, T. et al. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J. Virol. 73, 7524–7532 (1999).

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection;Viruses;2024-06-17

2. Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV‐1 neutralizing antibodies;Journal of Medical Virology;2024-06

3. Antiretroviral therapy and its cerebral vascular toxicity;HIV-Associated Neurocognitive Disorders;2024

4. Mosaic HIV-1 vaccination induces anti-viral CD8 ⁺ T cell functionality in the phase 1/2a clinical trial APPROACH;Journal of Virology;2023-10-31

5. Human Immunodeficiency Virus Vaccines;Plotkin's Vaccines;2023